Accession Number: | 0001104659-21-077869 |
Date: | 2021-06-03 |
Issuer: | MEDIFAST INC (MED) |
Original Submission Date: |
HALLQUIST CONSTANCE J.
C/O MEDIFAST, INC.,
100 INTERNATIONAL DRIVE
BALTIMORE,, MD 21202
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-03 | A | 679 | a | $0.00 | 6,984 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents the right to receive 679 shares of the issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the medifast, inc. directors' deferred compensation plan (amended and restated). these shares are granted from the issuer's 2012 share incentive plan and will vest in full on june 3, 2022. |